Doctor profile · Federal record
Dr. SARFRAZ AHMAD, MD
Pulmonary Disease Physician (CMS: PULMONARY DISEASE) · Sleep Medicine (Internal Medicine) Physician · GREENWOOD, IN
- NPI 1689850422
- Accepts Medicare
- 32 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
701 E COUNTY LINE RD, SUITE 101
GREENWOOD, IN 461431072
(317) 885-2860
fax (317) 885-8269
Credentials & registration
- NPI registered
- January 2008 — 18 yrs on file
- Profile last updated
- January 14, 2022
- Year of graduation
- 1994 — 32 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State license (1)
- Indiana #01075158A
- Medicaid
- IN #201300650
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1689850422. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,108
Distinct HCPCS
10
Medicare allowed
$116,412
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 256 | 140 | $75 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 209 | 135 | $111 | |
99291 |
Critical care, first 30-74 minutes | 136 | 84 | $201 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 101 | 64 | $121 | |
99231 |
Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 53 | 37 | $46 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 48 | 48 | $165 | |
99310 |
Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | 41 | 16 | $146 | |
99309 |
Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | 37 | 14 | $102 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 32 | 31 | $85 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 28 | 28 | $124 |
In context: peer comparison
Among 9 peers in this city , average services per provider: 88. This provider delivers 13× the peer median.Open Payments
Industry payments received
All-time total
$1,148
Transactions
58
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $210.50 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $181.02 | |
| GlaxoSmithKline, LLC. | 16 | $162.38 | |
| GENZYME CORPORATION | 7 | $135.30 | |
| Regeneron Healthcare Solutions, Inc. | 3 | $81.31 | |
| AstraZeneca Pharmaceuticals LP | 4 | $68.65 | |
| Shionogi Inc | 2 | $48.01 | |
| HARMONY BIOSCIENCES LLC | 2 | $43.54 | |
| Grifols USA, LLC | 2 | $41.87 | |
| Harmony Biosciences Llc | 1 | $39.86 | |
| United Therapeutics Corporation | 1 | $20.44 | |
| Azurity Pharmaceuticals, Inc. | 1 | $19.78 | |
| Novo Nordisk Inc | 1 | $18.21 | |
| Inspire Medical Systems, Inc. | 1 | $17.07 | |
| Mylan Specialty L.P. | 1 | $16.19 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
746
Patients
159
Total drug cost
$335,690
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 213 | 64 | $9,420 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 181 | 37 | $167,527 |
| Prednisone | Generic | 71 | 34 | $244 |
| Anoro Ellipta (Umeclidinium Brm/Vilanterol Tr) | Brand | 36 | 12 | $28,830 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 34 | 0 | $23,455 |
| Azithromycin | Generic | 28 | 0 | $296 |
| Amoxicillin | Generic | 24 | 0 | $75 |
| Eliquis (Apixaban) | Brand | 23 | 0 | $14,272 |
| Montelukast Sodium | Generic | 23 | 0 | $536 |
| Breztri Aerosphere (Budesonide/Glycopyr/Formoterol) | Brand | 22 | 0 | $19,086 |